New Topical Isotretinoin Cream Offers Localized Treatment Option for Mild Acne

A new topical isotretinoin cream offers a localized option for people with mild to moderate acne who want to limit exposure to medication throughout the body. Earlier studies of topical isotretinoin found improvements in acne lesions, while side effects were mainly concentrated at the application site. The cream may help manage breakouts, but it does not offer the same potential for lasting clearance as oral isotretinoin, which may be considered for persistent acne that has not responded to standard treatments, when medically appropriate.
The cream is being marketed in the U.S. as a new formulation of isotretinoin; although often dubbed “topical Accutane,” the article identifies it more precisely as topical isotretinoin, applied directly to the skin.
A cited 1992 study was a randomized, double-blind, placebo-controlled trial of 77 people and tested 0.05% isotretinoin gel; inflammatory lesions showed significant improvement by week 12.
The article says the prior evidence supports topical isotretinoin for blackheads, whiteheads and inflammatory breakouts—not just acne lesions in general.
Publishers
6
Articles
189
Reach
195